Skip to main content

Table 1 Baseline main clinical and demographic characteristics of HIV-infected patients based on rs10892151 genotype

From: Antiretroviral treatment-induced dyslipidemia in HIV-infected patients is influenced by the APOC3-related rs10892151 polymorphism

Characteristics at study entry

G/G carriers

(n= 190)

A/G carriers

(n= 18)

Age, years

39.1 (6.9)

37.9 (7.0)

Gender, n (%)

  

   Male

127 (66.8)

13 (72.2)

   Female

63 (33.2)

5 (27.8)

BMI, kg/m2

22.74 (2.9)

23.23 (3.6)

Risk factors for HIV, n (%)

  

   Intravenous drug use

114 (60.0)

11 (61.1)

   Heterosexual contact

57 (30.0)

5 (27.7)

   Male homosexual contact

19 (10.0)

2 (11.2)

HCV co-infection, n (%)

115 (60.5)

13 (72.2)

HIV-1 RNA viral load, copies/mL

246582 (776921)

336652 (863524)

CD4+ T cell count, cells/μL

448.9 (285.9)

435.1 (290.9)

Treatment scheme, n (%)

  

   NNRTI based

103 (54.2)

10 (55.5)

   PI based

87 (45.8)

8 (44.5)

Apo C-III, μg/mL

11.27 (4.9)

10.42 (4.7)

Total cholesterol, mmol/L

4.89 (1.2)

4.80 (1.2)

HDL-cholesterol, mmol/L

1.06 (0.4)

1.08 (0.4)

VLDL-cholesterol, mmol/L

0.87 (0.3)

0.64 (0.2)

LDL-cholesterol, mmol/L

2.91 (0.9)

2.88 (0.9)

Triglycerides, mmol/L

2.48 (2.0)

2.40 (2.0)

Glucose, mmol/L

5.39 (0.9)

5.51 (1.0)

CRP, mg/L

4.13 (5.4)

4.91 (6.2)

MCP-1, pg/mL

74.72 (41.8)

81.17 (43.1)

  1. Values are the mean and the standard deviation (SD), unless otherwise indicated. BMI, body-mass index